In addition, combination chemotherapies, such as regimens combining DFX, GEM, and albumin-bound paclitaxel, possibly have therapeutic advantages over albumin-bound paclitaxel with GEM in pancreatic cancer. The gene discussed is ALB; the disease is familial pancreatic carcinoma.